Abstract: According to an aspect of an embodiment, operations may include performing, based on weights and local field values associated with an optimization problem, a stochastic process with respect to changing a respective state of one or more variables that each represent a characteristic related to the optimization problem. The stochastic process may include performing trials with respect to one or more of the variables, in which a respective trial determines whether to change a respective state of a respective variable. The operations additionally may include determining an acceptance rate of state changes of the variables during the stochastic process and adjusting a degree of parallelism with respect to performing the trials based on the determined acceptance rate.

Abstract: The present invention is related to the field of CRISPR-Cas9 gene editing platforms. In particular, the present invention has identified Type II-C Cas9 anti-CRISPR (Acr) inhibitors that control Cas9 gene editing activity. Co-administration of such Acr inhibitors may provide an advantageous adjunct in permitting safe and practical biological therapeutics through spatial or temporal control of Cas9 activity; controlling Cas9-based gene drives in wild populations to reduce the ecological consequences of such forced inheritance schemes; and contributing to general research into various biotechnological, agricultural, and medical applications of gene editing technologies.

Abstract: The present application relates to the treatment of nematode infections.

Abstract: Described herein is a genetic modifier of cystic fibrosis (CF), which may serve as a predictor of the efficacy of a CFTR-directed therapy. SNPs rs7512462 or rs2869027 in non-coding regions of SLC26A9 are shown to correlate with CF lung disease severity in patients having CFTR mutations that leave protein at the cell surface, e.g. gating mutations such as G551D. It is also shown that patient response to Ivacaftor correlates with SLC26A9 genotype. Given the biology of SLC26A9, risk alleles of SLC26A9 should correlate with reduced SLC26A9. SLC26A9 activity (marked by e.g. genotype or expression level) is therefore a predictor of treatment efficacy for any CFTR-directed therapeutic, such as Ivacaftor or Lumacaftor. Associated methods of selecting and treating patients are described, along with related kits, uses, and drug discovery platforms.

Abstract: There is provided a catalytic system including a fibrous hydrophobic substrate, a first layer having a first layer thickness including copper or copper alloy nanoparticles covering the polymeric substrate, and a second layer having a second layer thickness over the first layer and including amorphous nitrogen-doped carbon, wherein the catalytic system includes confined interlayer spaces defined by regions where the first layer and the second layer are spaced apart from each other. The catalytic system can be used for catalyzing the electrochemical reduction of carbon dioxide, carbon monoxide, or a combination thereof. Thus, there is also provided a method for the electrochemical reduction of carbon dioxide, carbon monoxide, or a combination thereof, using the catalytic system.

Abstract: A method and system for generating a protein sequence is implemented using a computer-implemented neural network. An empty or partially filed sequence of node elements, representing amino acid positions of the protein sequence, and an edge index, having edge elements defining physical interaction between amino acid positions, are received. The computer-implemented neural network operates to determine enhanced edge attribute values for edge elements of the edge index and enhanced amino acid values for node elements of the sequence. Amino acid values are generated for elements of the partially filed sequence having missing values.

Abstract: Techniques for use in connection with performing optimization using an objective function that maps elements in a first domain to values in a range. The techniques include using at least one computer hardware processor to perform: identifying a first point at which to evaluate the objective function at least in part by using an acquisition utility function and a probabilistic model of the objective function, wherein the probabilistic model depends on a non-linear one-to-one mapping of elements in the first domain to elements in a second domain; evaluating the objective function at the identified first point to obtain a corresponding first value of the objective function; and updating the probabilistic model of the objective function using the first value to obtain an updated probabilistic model of the objective function.

Abstract: Disclosed herein are multifunctional nanoparticle compositions. The compositions can be useful for the treatment of cancer by enhancing the anti-tumor effectiveness of radiation directed to a tissue, cell or a tumor and the methods of use thereof. The multifunctional nanoparticle composition comprises a metal oxide nanoparticle core; a functional coating on the surface of the metal oxide nanoparticle core; and a matrix carrier in which the coated nanoparticle is embedded.

Abstract: A system for providing both driving and charging functionality by using a plurality of traction inverters and a plurality of energy storage devices coupled to one another across the electric motor; an AC/DC converter front-end circuit interfacing the first/second traction inverters and the power source; a controller circuit configured to control operating characteristics of the AC/DC converter front-end circuit, wherein the first/second traction inverters are provided gating signals to one or more switching gates of the first/second traction inverters to shape power characteristics of power delivered to the first/second energy storage devices, from the power source.

Abstract: The present disclosure provides a method of producing uniformly sized organoids/multicellular spheroids using a microfluidic device having an array of microwells. The method involves several successive steps. First, a microfluidic device containing parallel rows of microwells that are connected with a supplying channel is filled with a wetting agent. The wetting agent is a liquid that is immiscible in water. For example, the wetting agent may be an organic liquid such as oil. In the next step, the agent in the supplying channel and the microwells is replaced with a suspension of cells in an aqueous solution that contains a precursor for a hydrogel. Next, the aqueous phase in the supplying channel is replaced with the agent, which leads to the formation of an array of droplets of cell suspension in the hydrogel precursor solution, which were compartmentalized in the wells. The droplets are then transformed into cell-laden hydrogels.

Abstract: Fully homomorphic encryption integrated circuit (IC) chips, systems and associated methods are disclosed. In one embodiment, a method of operation for a number theoretic transform (NTT) butterfly circuit is disclosed. The (NTT) butterfly circuit includes a high input word path cross-coupled with a low word path. The high input word path includes a first adder/subtractor, and a first multiplier. The low input word path includes a second adder/subtractor, and a second multiplier. The method includes selectively bypassing the second adder/subtractor and the second multiplier, and reconfiguring the low and high input word paths into different logic processing units in response to different mode control signals.

Abstract: A new class of mass-tag polymers is provided, which include enriched metal isotopes such as zirconium and hafnium mass tags. The chemistry of these new mass tags are different from that of lanthanide mass tags, and opens up new mass channels that can be used in mass cytometry. These polymers may be used for mass cytometry, therapeutic delivery of a radioactive isotope, or screening of a therapeutic isotope. Aspects include a kit, method of making, and method of using a polymer, isotopic composition, or both. A kit may include a polymer. The polymer may include pendant groups that chelate an enriched isotope, such as zirconium and/or hafnium. The kit may include an isotopic composition comprising an enriched zirconium or hafnium isotope. Polymers may be conjugated to a biologically active material. Aspects may also include making a kit. Aspects include use of a kit, such as for mass cytometry.

Abstract: The present disclosure provides electrical architecture for electrochemical impedance spectroscopy (EIS). An EIS circuit comprises at least two current regulators and an electrical energy storage device, which are connected with one or more electrochemical cells in a configuration that decouples power flowing into the respective current regulators. The presence of the electrical energy storage device enables each regulator to operate simultaneously at lower power levels while inducing the desired EIS perturbation current. Operation at low power allows lower volume and cost for the same current compared to only dissipative or non-dissipative current regulators. Further, the electrical energy storage device allows the power flowing through the current regulators to be varied independently in order to achieve the desired EIS perturbation current while a minimum amount of heat is generated in the circuit, thus allowing the circuit to occupy minimal size and incur minimal cost.

Abstract: Disclosed are crosslinked particles (e.g., microparticles) that are capable of storing and releasing drugs. The particles can be macroparticles, microparticles, or nanoparticles and can be composed of polyester backbones. The particles can be loaded with a drug. The particles can degrade in vivo to release the drug. The particles can be prepared by crosslinking functionalized polyester backbones and loaded with a given drug. The particles of the present disclosure can be injected with a syringe. In some embodiments, the particles of the present disclosure are administered in connection with a surgery and release the drug after the site of the surgery for a period of 1-6 months.

Abstract: A fortified salt mixture includes sodium chloride salt grains and a multi-supplement food-additive admixed with the sodium chloride salt grains. The multi-supplement food additive includes particles, and each particle includes a core having a first supplement and a binder, a coating on the core, and a second supplement in the core and/or in the coating. A method for fortifying salt ncludes combining a first supplement, a second supplement, a binder and a coating to yield a multi-supplement food-additive; and admixing the multi-supplement food-additive with sodium chloride salt grains.

Abstract: Energy-efficient epipolar imaging is applied to the ToF domain to significantly expand the versatility of ToF sensors. The described system exhibits 15+ m range outdoors in bright sunlight; robustness to global transport effects such as specular and diffuse inter-reflections; interference-free 3D imaging in the presence of many ToF sensors, even when they are all operating at the same optical wavelength and modulation frequency; and blur- and distortion-free 3D video in the presence of severe camera shake. The described embodiments are broadly applicable in consumer and robotics domains.

Abstract: The present application pertains to methods of using indole-oxadiazole compounds of Formula I to modulate cannabinoid receptor activity: I In particular diseases, disorders or conditions that benefit from modulating cannabinoid receptor activity, such as non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), schizophrenia, bipolar disorder, psychosis, metabolic syndrome, type-2 diabetes, dyslipidaemia, obesity, eating disorders, cardiovascular diseases and disorders, and other conditions as described herein, may be treated. Also included in the present application are certain novel compounds of Formula Ia and pharmaceutical compositions comprising these compounds.

Abstract: There is provided a system, method, and computer program for digital enhancement of hippocampal replay. In an embodiment, the method includes: creating one or more digital memories, each digital memory created by: receiving a tag associated with the digital memory from a user; receiving a captured digital memory from the user; and associating one or more additional attributes with the digital memory; creating a replay session, the replay session comprising one or more digital memories, by: associating a target digital memory with the replay session; and associating one or more other digital memories with the replay session if such one or more other digital memories meet a measure of commonality with the target digital memory, the measure of commonality at least based on the additional attributes; and displaying the replay session to the user within a predetermined period.

Abstract: A system and method for detecting interactions between a first protein or fragment thereof (bait protein) and a second protein or fragment thereof (prey protein) comprising: (a) a bait construct comprising the bait protein, a first epitope tag and an intein N-terminal fragment (IN); and (b) a prey construct comprising the prey protein, a second epitope tag, and an intein C-terminal fragment (IC).

Abstract: The invention relates to a catalyst system for catalyzing conversion of carbon dioxide into multi-carbon compounds comprising a boron-doped copper catalytic material and associated methods.